Evidence method
Level · gp.fundamentals.capex_revenue_ratio
3.46% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CTKB · Jun 30, 2025
Cytek Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-25-038422General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.24% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-2.18% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
108.52% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
52.34% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-23.30% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
19.35% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
14.89% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Sep 30, 20210/7 normalizedLevel 3Dec 31, 20210/7 normalizedLevel 3Mar 31, 20220/7 normalizedLevel 3Jun 30, 20220/8 normalizedLevel 3Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20235/8 normalizedLevel 3Sep 30, 20237/8 normalizedLevel 3Dec 31, 20237/8 normalizedLevel 3Mar 31, 20247/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 2.05%
- Current
- 3.46%
- Delta
- 1.41%
- Previous
- -0.30%
- Current
- 0.24%
- Delta
- 0.54%
- Previous
- -7.59%
- Current
- -2.18%
- Delta
- 5.41%
- Previous
- 109.38%
- Current
- 108.52%
- Delta
- -0.86%
- Previous
- 48.62%
- Current
- 52.34%
- Delta
- 3.72%
- Previous
- -36.12%
- Current
- -23.30%
- Delta
- 12.82%
- Previous
- 23.46%
- Current
- 19.35%
- Delta
- -4.10%
- Previous
- 15.99%
- Current
- 14.89%
- Delta
- -1.10%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CTKB Fundamental State →Analogous To · CTKB state analogue 1 →Transitioned To · CTKB Fundamental State →Transitioned To · CTKB CAPEX_INTENSITY_INCREASED →Transitioned To · CTKB CASH_GENERATION_INCREASED →Transitioned To · CTKB GROWTH_INCREASED →Transitioned To · CTKB INVENTORY_PRESSURE_DECREASED →Transitioned To · CTKB MARGIN_INCREASED →Transitioned To · CTKB PROFITABILITY_INCREASED →Transitioned To · CTKB R_AND_D_INTENSITY_DECREASED →Transitioned To · CTKB SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.